Myrto Barmpouni
Athens, ESYE31, Greece
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Cost-effectiveness analysis of 20-valent pneumococcal conjugate vaccine (PCV20) to prevent pneumococcal disease in the Greek pediatric population.
Journal: Expert review of vaccines
Published: June 03, 2025
Burden of respiratory syncytial virus disease in infants and the potential value of maternal immunization in Greece.
Journal: Frontiers in public health
Published: April 14, 2025
Cost-Effectiveness of Bivalent Respiratory Syncytial Virus Prefusion F Vaccine for Prevention of Respiratory Syncytial Virus Among Older Adults in Greece.
Journal: Vaccines
Published: September 12, 2024
Moderate to Severe Osteoarthritis: What is the Economic Burden for Patients and the Health Care System? Insights from the "PONOS" Study.
Journal: Cartilage
Published: December 13, 2023
Estimating the Clinical and Economic Impact of Switching from the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) to Higher-Valent Options in Greek Infants.
Journal: Vaccines
Published: July 12, 2023
Health and economic outcomes of 20-valent pneumococcal conjugate vaccine compared to 15-valent pneumococcal conjugate vaccine strategies for adults in Greece.
Journal: Frontiers in public health
Published: May 26, 2023
Clinical and Economic Value of Reducing Antimicrobial Resistance in the Management of Hospital-Acquired Infections with Limited Treatment Options in Greece.
Journal: Infectious diseases and therapy
Published: May 16, 2023
Estimating the Clinical and Economic Impact of Introducing a New Antibacterial into Greek Clinical Practice for the Management of Hospital-Acquired Infections with Limited Treatment Options.
Journal: Infectious diseases and therapy
Published: August 24, 2022
Showing 1-8 of 8
Last Updated: 09/26/2026